COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Preoperative CHG Cloth (2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02291601
Recruitment Status : Completed
First Posted : November 14, 2014
Last Update Posted : December 8, 2015
Information provided by (Responsible Party):
Medline Industries

Brief Summary:
Demonstrate the reduction of bacteria on the skin.

Condition or disease Intervention/treatment Phase
Surgical Skin Preparation Drug: Chlorhexidine Gluconate Other: Vehicle Drug: 2% Chlorhexidine Gluconate Solution Phase 3

Detailed Description:
Examine the antimicrobial cloth effects on bacteria of the abdomen and groin area.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 879 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Assessment of the Antimicrobial Efficacy of 2% CHG Cloth Preoperative Skin Preparation
Study Start Date : October 2014
Actual Primary Completion Date : September 2015
Actual Study Completion Date : September 2015

Arm Intervention/treatment
Experimental: Chlorhexidine Gluconate Cloth
2% CHG, single application
Drug: Chlorhexidine Gluconate
comparison with other CHG products

Placebo Comparator: Vehicle Cloth
Excipients on cloth
Other: Vehicle
Cloth with Excipients no CHG

Active Comparator: Active Chlorhexidine gluconate solution
Dynahex 2% CHG
Drug: 2% Chlorhexidine Gluconate Solution
CHG solution
Other Name: DynaHex

Primary Outcome Measures :
  1. Count the number of bacteria on skin [ Time Frame: 10 minutes to 8 hours ]
    Bacteria on the skin will be evaluated at time 0, 10 minutes, 6 hours and 8 hours after treatment.

Secondary Outcome Measures :
  1. Assess the side effects on the skin [ Time Frame: 10 min to 8 hours ]
    Treated skin will be assessed for any irritation.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   16 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Males or Females
  • 16 years of age or older
  • Signed informed consent
  • Good Health
  • Six inches of abdomen and groin areas without tattoos, or skin disorders

Exclusion Criteria:

  • Dermatological Conditions
  • Sensitivity to latex
  • Sensitivity to CHG

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02291601

Layout table for location information
United States, Montana
Butte, Montana, United States, 59701
Sponsors and Collaborators
Medline Industries
Layout table for investigator information
Principal Investigator: C Beausoleil BS
Layout table for additonal information
Responsible Party: Medline Industries Identifier: NCT02291601    
Other Study ID Numbers: R13-052
First Posted: November 14, 2014    Key Record Dates
Last Update Posted: December 8, 2015
Last Verified: December 2015
Additional relevant MeSH terms:
Layout table for MeSH terms
Chlorhexidine gluconate
Anti-Infective Agents, Local
Anti-Infective Agents
Dermatologic Agents